← Back to all trials
Not Yet Recruiting
NCT05630170
The SMART-LV Pilot Study
Conditions: Left Ventricular Systolic Dysfunction
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 20
Sponsor: Yale University
Location: United States
Summary
The goal of this pilot study is to evaluate the prospective performance of an image-based, smartphone-adaptable artificial intelligence electrocardiogram (AI-ECG) strategy to predict and detect left ventricular systolic dysfunction (LVSD) in a real-world setting.
Eligibility Criteria
Inclusion Criteria:Provision of signed and dated informed consent form.Stated willingness to comply with all study procedures and availability for the duration of the studyExclusion Criteria:Patients who have undergone a prior echocardiogram.Patients with a prior diagnosis of left ventricular dysfunction, based on a documented low ejection fraction (EF) in the medical record.Patients with an intermediate predicted probability of low EF (10 to 80%)Patients with a prior diagnosis of heart failure as determined by International Classification of Diseases-10 diagnosis code for heart failure.Research opt-out patients
Source: ClinicalTrials.gov (NCT05630170). StuddyBuddy aggregates publicly available trial information.